Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RCUS

Arcus Biosciences Inc

May 29 • 04:00PM ET

25.34

+0.86 3.51 %

Healthcare • Biotechnology • USA • Mid • NYSE

Peers: CGON ERAS TNGX KYMR NUVL AXSM BMRN INCY RYTM KRYS

| Held by: IJR VTI XBI IWM VB VXF SPSM IBB VBK IWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.18	Insider Own	33.50%	Shs Outstand	125.50M	Perf Week	6.16%
Market Cap	3.19B	Forward P/E	-	EPS next Y	-3.32	Insider Trans	-0.65%	Shs Float	83.64M	Perf Month	5.01%
Enterprise Value	2.48B	PEG	-	EPS next Q	-0.89	Inst Own	66.52%	Short Float	13.02%	Perf Quarter	24.40%
Income	-369.00M	P/S	13.50	EPS this Y	-11.14%	Inst Trans	-2.34%	Short Ratio	9.26	Perf Half Y	4.37%
Sales	236.00M	P/B	6.07	EPS next Y	9.23%	ROA	-34.28%	Short Interest	10.89M	Perf YTD	6.34%
Book/sh	4.18	P/C	3.88	EPS next 5Y	13.09%	ROE	-69.95%	52W High	28.72 -11.77%	Perf Year	166.46%
Cash/sh	6.54	P/FCF	-	EPS past 3/5Y	3.94% -7.95%	ROIC	-59.13%	52W Low	7.91 220.35%	Perf 3Y	15.02%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	30.16% 26.08%	Gross Margin	96.19%	Volatility	5.47% 5.02%	Perf 5Y	2.10%
Dividend TTM	-	EV/Sales	10.50	EPS Y/Y TTM	24.05%	Oper. Margin	-168.64%	ATR (14)	1.29	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.04	Sales Y/Y TTM	67.38%	Profit Margin	-156.36%	RSI (14)	57.49	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	4.04	EPS Q/Q	10.32%	SMA20	2.90%	Beta	0.84	Target Price	34.82
Payout	-	Debt/Eq	0.22	Sales Q/Q	-39.29%	SMA50	7.22%	Rel Volume	1.85	Prev Close	24.48
Employees	601	LT Debt/Eq	0.19	Earnings	May 05 AMC	SMA200	26.65%	Avg Volume	1.18M	Price	25.34
IPO	Mar 15, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.88% -42.34%	Trades		Volume	2,179,922	Change	3.51%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)